Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Skeoch (Manchester, United Kingdom), N. Weatherley (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), A. Oldroyd (Manchester, United Kingdom), C. Johns (Sheffield, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Giollo (Leeds, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Waterton (Manchester, United Kingdom), M. Buch (Leeds, United Kingdom), K. Linton (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), B. Stephen (Sheffield, United Kingdom), N. Chaudhuri (Manchester, United Kingdom). Drug induced interstitial lung disease: a systematic review. 2244

Member's Comments

No comment yet.

Related content which might interest you: Oxygen therapy for interstitial lung disease: a systematic review Source: Eur Respir Rev 2017; 26: 160080 Year: 2017 Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 Year: 2021 Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence Source: Eur Respir Rev, 27 (150) 180074; 10.1183/16000617.0074-2018 Year: 2018 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 Interstitial lung disease in childhood. A clinical review Source: Eur Respir J 2004; 24: Suppl. 48, 624s Year: 2004 Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD) Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Rituximab-induced lung disease. Case and review Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Sinonasal inflammation in COPD: a systematic review Source: Eur Respir J 2013; 42: 1402-1411 Year: 2013 Fibrotic interstitial lung diseases and air pollution: a systematic literature review Source: Eur Respir Rev, 29 (157) 200093; 10.1183/16000617.0093-2020 Year: 2020 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Source: Eur Respir J 2015; 46: 1113-1130 Year: 2015 Drug induced lung disease: 11 cases Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015 Pesticide exposure and lung function: a systematic review and meta-analysis Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases Year: 2019 The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Diffuse parenchymal drug related lung disease: report of a series Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Physical activity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Clinical use of interstitial lung disease guidelines Source: Eur Respir Mon; 2009: 46: 386–395 Year: 2009